Nombre científico: Origanum majorana
CAS Nº: 8015-01-8 / 84082-58-6
EINECS: 282-004-4
Partes de la planta: Toda la parte aérea
Origen: Plantación Propia
Proceso: Arrastre de vapor
Principales componentes: 1,8-CINEOLE 45%-65%, LINALOL 8%-30%
Perfil olfativo: Característico, cineólico, suave aroma a hierbas, penetrante, dulce y reconfortante. sedantes, calmantes.
PRODUCTOR DE ACEITE ESENCIAL DE MEJORANA
Curiosidades:
| Parte de la planta | Modo de proceso |
Usos |
| Aceite esencial | Varios métodos | Sabor y conservas |
| Aceite esencial o planta entera | Varios métodos | Cicatrización de la herida |
| Cobertura de flores o aceite esencial | Varios métodos | Sedante |
| Cobertura esencial o entera de plantas y/o flores | Varios métodos | Antiespasmódico |
| Aceite esencial | Varios métodos | Infecciones microbianas y virales |
Porcentaje relativo de cada compuesto del cromatograma presentado de LAVANDA
| Compounds | Relative percentage |
| n-Hexanol | – |
| α-Thujene | t |
| α-Pinene | 5.0 |
| Camphene | 1.3 |
| Thuja-2,4(10)-diene * | t |
| Sabinene | 0.7 |
| 1-Octen-3-ol | – |
| β-Pinene | 6.2 |
| Dehydro-1,8-cineole | t |
| β-Myrcene | 1.1 |
| α-Phellandrene | t |
| α-Terpinene | 0.1 |
| p-Cymene | 0.4 |
| 1,8-Cineole | 40.2 |
| β-Phellandrene | – |
| Limonene | 4.0 |
| cis-β-Ocimene | 2.0 |
| trans-β-Ocimene | 0.1 |
| γ-Terpinene | 0.4 |
| trans-Sabinene hydrate | t |
| cis-Linalool oxide (furanoid) | t |
| Fenchone | 0.2 |
| trans-Linalool oxide (furanoid) | – |
| Terpinolene | 0.3 |
| Linalool | 5.0 |
| Propionic acid hexyl ester | t |
| α-Campholenal | t |
| Nopinone * | – |
| trans-p-2-Menthen-1-ol | t |
| Camphor | 19.9 |
| cis-Verbenol | 0.2 |
| trans-Verbenol | t |
| Hexyl isobutanoate | – |
| δ-Terpineol | 0.6 |
| Borneol | 0.6 |
| Lavandulol | t |
| Cryptone * | t |
| Terpinen-4-ol | 0.8 |
| Myrtenal | t |
| α-Terpineol | 1.0 |
| Myrtenol | t |
| Hexyl butyrate | 0.2 |
| trans-Carveol | t |
| Cumin aldehyde | t |
| Carvone | t |
| Hexyl 2-methyl butyrate | t |
| Hexyl isovalerate | t |
| Linalyl acetate | – |
| Bornyl acetate | t |
| Lavandulyl acetate | – |
| Hexyl tiglate | t |
| α-Terpenyl acetate | – |
| α-Cubebene | – |
| Hexyl hexanoate | t |
| β-Bourbonene | t |
| α-Gurjunene | – |
| β-Caryophyllene | 4.1 |
| Aromadendrene | – |
| α-Humulene | t |
| trans-β-Farnesene | t |
| trans-Cadina-1(6),4-diene | t |
| γ-Muurolene | t |
| Germacrene D | 0.8 |
| β-Selinene | – |
| α-Muurolene | t |
| γ-Cadinene | 0.9 |
| trans-Calamenene | t |
| δ-Cadinene | 1.1 |
| β-Caryophyllene oxide | 1.5 |
| Ledol | t |
| epi-Cubenol | – |
| T-Cadinol | 0.7 |
| α-Cadinol | 0.2 |
| α-Bisabolol | t |
| Grouped components | |
| Monoterpene hydrocarbons 21.6 | |
| Oxygen-containing monoterpenes 68.5 | |
| Sesquiterpene hydrocarbons 6.9 | |
| Oxygen-containing sesquiterpenes 2.4 | |
| Others 0.2 |
| Effect | Route used in the experiment | Source |
| Anti-inflammatory and Antifungal | In vitro: cell culture – Manage the dermatophytosis and/or inflammatory related
diseases |
[2] |
| Antibacterial and Antioxidant | In vitro: cell culture – Inhibitory effect
Salmonella spp., |
[3] |
| Antioxidant and Hyaluronidase inhibition activity | In vitro: enzymatic
Model – Pharmaceutical ingredients for the treatment of diseases related to oxidative stress, extracellular matrix breakdown and hyaluronic acid homeostasis |
[4] |
| Antioxidant and lipoxygenase inhibitory activity | In vitro: enzymatic model
– Pharmaceutical ingredients for several skin diseases. |
[5] |
| Neuroprotective | In vivo: rats – Neuroprotective effects against scopolamineinduced
oxidative stress in the brain |
[6] |
| Anxiolytic | In vivo: rats – Possible preventing mechanism on the vicious
cycle of anticipatory anxiety that leads to fearful cognition and the symptoms of anxiety in aversive situations |
[7] |
References
. doi:10.1177/1934578×1801301037
